Ameriprise’s iShares iBonds Dec 2033 Term Corporate ETF IBDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.5M Buy
716,884
+48,018
+7% +$1.24M ﹤0.01% 1590
2026
Q1
$17.3M Buy
668,866
+75,198
+13% +$1.96M ﹤0.01% 1516
2025
Q4
$15.5M Buy
593,668
+39,733
+7% +$1.04M ﹤0.01% 1596
2025
Q3
$14.5M Buy
553,935
+377,989
+215% +$9.81M ﹤0.01% 1629
2025
Q2
$4.56M Buy
175,946
+165,821
+1,638% +$4.21M ﹤0.01% 2438
2025
Q1
$259K Buy
+10,125
New +$256K ﹤0.01% 3721

Other funds holding IBDY

Ameriprise's IBDY Position: Q2 2026 in Review

Ameriprise increased its iShares iBonds Dec 2033 Term Corporate ETF (IBDY) stake by 7.2% in Q2 2026, buying an estimated $1.24M and bringing the position to 716,884 shares worth $18.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

Ameriprise first reported a position in IBDY in Q1 2025 and has held it in 6 quarters since. 168 funds tracked by Wall St. Rank hold IBDY as of Q2 2026.

  • Ameriprise held 716,884 shares of iShares iBonds Dec 2033 Term Corporate ETF worth $18.5M as of Q2 2026.
  • Ameriprise bought 48,018 iShares iBonds Dec 2033 Term Corporate ETF shares in Q2 2026, an estimated $1.24M.
  • iShares iBonds Dec 2033 Term Corporate ETF made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1590 holding.
  • Ameriprise first reported a position in iShares iBonds Dec 2033 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
  • 168 funds tracked by Wall St. Rank held iShares iBonds Dec 2033 Term Corporate ETF as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.